Cargando…
Comparison of SOX-10, HMB-45, and Melan-A in Benign Melanocytic Lesions
PURPOSE: Different immunohistochemical stains are used in dermatopathology to stain melanocytes and diagnose benign and malignant melanocytic lesions. METHODS: SOX-10, HMB-45, and Melan-A immunohistochemical stains were used to assess 32 biopsy specimens with a histologic diagnosis of lentigo. The t...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8502009/ https://www.ncbi.nlm.nih.gov/pubmed/34675577 http://dx.doi.org/10.2147/CCID.S333376 |
_version_ | 1784580793713033216 |
---|---|
author | Dass, Sabrina E Huizenga, Taryn Farshchian, Mehdi Mehregan, Darius R |
author_facet | Dass, Sabrina E Huizenga, Taryn Farshchian, Mehdi Mehregan, Darius R |
author_sort | Dass, Sabrina E |
collection | PubMed |
description | PURPOSE: Different immunohistochemical stains are used in dermatopathology to stain melanocytes and diagnose benign and malignant melanocytic lesions. METHODS: SOX-10, HMB-45, and Melan-A immunohistochemical stains were used to assess 32 biopsy specimens with a histologic diagnosis of lentigo. The total number of melanocytes stained with each immunohistochemical stain was counted and an average count was obtained from two readings. RESULTS: Analysis of the data revealed a significant difference in staining melanocytes between these three immunostains (p=0.0010, ANOVA). SOX-10 stained 0.195 more melanocytes than HMB-45 (p=0.0026). Similarly, Melan-A stained 0.195 more melanocytes than HMB-45 (p=0.0011). However, the difference between SOX-10 and Melan-A was not statistically significant (p=0.9810). CONCLUSION: SOX-10 and Melan-A immunostaining stain more melanocytes than HMB-45. No significant difference was noted between Melan-A and SOX-10. |
format | Online Article Text |
id | pubmed-8502009 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-85020092021-10-20 Comparison of SOX-10, HMB-45, and Melan-A in Benign Melanocytic Lesions Dass, Sabrina E Huizenga, Taryn Farshchian, Mehdi Mehregan, Darius R Clin Cosmet Investig Dermatol Original Research PURPOSE: Different immunohistochemical stains are used in dermatopathology to stain melanocytes and diagnose benign and malignant melanocytic lesions. METHODS: SOX-10, HMB-45, and Melan-A immunohistochemical stains were used to assess 32 biopsy specimens with a histologic diagnosis of lentigo. The total number of melanocytes stained with each immunohistochemical stain was counted and an average count was obtained from two readings. RESULTS: Analysis of the data revealed a significant difference in staining melanocytes between these three immunostains (p=0.0010, ANOVA). SOX-10 stained 0.195 more melanocytes than HMB-45 (p=0.0026). Similarly, Melan-A stained 0.195 more melanocytes than HMB-45 (p=0.0011). However, the difference between SOX-10 and Melan-A was not statistically significant (p=0.9810). CONCLUSION: SOX-10 and Melan-A immunostaining stain more melanocytes than HMB-45. No significant difference was noted between Melan-A and SOX-10. Dove 2021-10-05 /pmc/articles/PMC8502009/ /pubmed/34675577 http://dx.doi.org/10.2147/CCID.S333376 Text en © 2021 Dass et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Dass, Sabrina E Huizenga, Taryn Farshchian, Mehdi Mehregan, Darius R Comparison of SOX-10, HMB-45, and Melan-A in Benign Melanocytic Lesions |
title | Comparison of SOX-10, HMB-45, and Melan-A in Benign Melanocytic Lesions |
title_full | Comparison of SOX-10, HMB-45, and Melan-A in Benign Melanocytic Lesions |
title_fullStr | Comparison of SOX-10, HMB-45, and Melan-A in Benign Melanocytic Lesions |
title_full_unstemmed | Comparison of SOX-10, HMB-45, and Melan-A in Benign Melanocytic Lesions |
title_short | Comparison of SOX-10, HMB-45, and Melan-A in Benign Melanocytic Lesions |
title_sort | comparison of sox-10, hmb-45, and melan-a in benign melanocytic lesions |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8502009/ https://www.ncbi.nlm.nih.gov/pubmed/34675577 http://dx.doi.org/10.2147/CCID.S333376 |
work_keys_str_mv | AT dasssabrinae comparisonofsox10hmb45andmelanainbenignmelanocyticlesions AT huizengataryn comparisonofsox10hmb45andmelanainbenignmelanocyticlesions AT farshchianmehdi comparisonofsox10hmb45andmelanainbenignmelanocyticlesions AT mehregandariusr comparisonofsox10hmb45andmelanainbenignmelanocyticlesions |